Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by 24minus7on Feb 01, 2020 1:41am

93 Views

Post# 30628516

RE:RE:Let's Meet up in Vancouver over a lunch or a beer

I ask for your understanding, but a flight time of about 13 hours (one-way) unfortunately does not justify a short detour to Vancouver. Nevertheless, we can meet in the course of 2020, as soon as the SBM achievements are fully reflected in the share price and we can celebrate the successes and our newly acquired wealth together.

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features